ArticleInfectious diseases and therapy2020

Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients.

Adam G Pizzuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.